AGIO
$31.32-3.09%
Agios Pharmaceuticals Inc.Stock · HealthcareRussell 2000 0.07%Nasdaq Composite 0.007%Russell 3000 0.003%US Stock Market 0.003%
AGIO financial statements
The full income statement, balance sheet, and cash-flow statement for Agios Pharmaceuticals Inc. (AGIO), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 56.9M2024-09 57.0M2024-12 57.3M2025-03 57.9M2025-06 58.1M2025-09 58.3M2025-12 58.6M2026-03 59.5M2026-06 59.7M+4.9% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 54.0M+48.0% | 36.5M+36.1% | 26.8M+88.4% | 14.2M | 0.00 | |
| Cost of revenue | 6.34M+52.3% | 4.17M+44.6% | 2.88M+69.1% | 1.70M | 0.00 | |
| Research & development | 340M+12.7% | 301M+1.9% | 296M+5.6% | 280M+8.9% | 257M+16.4% | |
| Selling, general & administrative | 180M+15.0% | 157M+30.8% | 120M-1.5% | 122M+0.2% | 121M+5.5% | |
| Operating income | -472M-10.9% | -426M-8.7% | -391M-0.6% | -389M-2.8% | -378M-12.7% | |
| Interest & investment income | — | — | — | 12.8M+1430.3% | 836K-87.4% | |
| Other non-operating income | 1.96M-69.8% | 6.49M+7.1% | 6.05M-10.3% | 6.75M-53.2% | 14.4M | |
| Pre-tax income | -414M-157.6% | 718M+303.9% | -352M-51.9% | -232M+35.0% | -357M-8.3% | |
| Income tax | -1.02M-102.3% | 44.2M | 0.00 | 0.00 | — | |
| -413M-161.3% | 674M+291.4% | -352M-51.9% | -232M-114.4% | 1.60B+590.2% | ||
| Income from continuing operations | — | — | -352M-51.9% | -232M+35.0% | -357M-8.3% | |
| -$7.12-161.2% | $11.64+283.9% | -$6.33-49.6% | -$4.23-115.9% | $26.55+660.1% | ||
| EPS (basic) | -$7.12-160.0% | $11.86+287.4% | -$6.33-49.6% | -$4.23-115.9% | $26.55+660.1% | |
| Weighted-avg shares (basic) | 58.0M+2.1% | 56.8M+2.1% | 55.7M+1.6% | 54.8M-9.4% | 60.4M-12.4% | |
| Weighted-avg shares (diluted) | 58.0M+0.1% | 57.9M+4.0% | 55.7M+1.6% | 54.8M-9.4% | 60.4M-12.4% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 942M-2.4% | 966M+15.8% | 834M+0.1% | 833M-21.7% | 1.06B+67.2% | ||
| Cash & equivalents | 89.1M+16.9% | 76.2M-13.6% | 88.2M-36.7% | 139M-31.4% | 203M+59.4% | |
| Cash & short-term investments | 1.20B-20.0% | 1.50B+86.0% | 806M-26.7% | 1.10B-14.5% | 1.29B+91.9% | |
| Inventory | 32.9M+19.2% | 27.6M+44.8% | 19.1M+124.6% | 8.49M | 0.00-100.0% | |
| Prepaid expenses | 44.1M+9.9% | 40.2M+14.7% | 35.0M-10.1% | 39.0M-2.2% | 39.8M+150.7% | |
| 1.30B-22.0% | 1.66B+77.5% | 937M-24.3% | 1.24B-13.8% | 1.44B+68.6% | ||
| Property, plant & equipment | 10.8M-7.7% | 11.7M-24.1% | 15.4M-33.1% | 23.0M-20.5% | 28.9M-6.1% | |
| Operating lease right-of-use | 30.5M-29.0% | 42.9M-21.2% | 54.4M-16.5% | 65.1M-13.3% | 75.1M-11.3% | |
| Other non-current assets | 3.93M-16.8% | 4.72M+16.4% | 4.06M+2.6% | 3.96M+36.4% | 2.90M | |
| 82.2M+1.3% | 81.2M+19.4% | 68.0M+8.5% | 62.6M+4.7% | 59.8M-36.6% | ||
| Accounts payable | 18.4M+10.3% | 16.6M+70.2% | 9.78M-47.5% | 18.6M+11.5% | 16.7M-5.8% | |
| Accrued liabilities | 45.5M-3.0% | 46.9M+8.6% | 43.2M+42.2% | 30.4M-5.1% | 32.0M+3.8% | |
| Deferred revenue | — | — | — | — | 0.00 | |
| Current lease liability | 18.4M+9.6% | 16.8M+11.8% | 15.0M+9.8% | 13.7M+26.2% | 10.8M+52.7% | |
| Finance lease liability (current) | — | — | — | 0.00-100.0% | 331K+4.4% | |
| 104M-14.8% | 122M-3.1% | 126M-8.6% | 138M-5.4% | 146M-67.9% | ||
| Non-current lease liability | 21.8M-45.7% | 40.2M-29.4% | 57.0M-20.8% | 72.0M-16.0% | 85.7M-12.1% | |
| Operating lease liability (total) | 40.2M-29.4% | 57.0M-20.8% | 72.0M-16.0% | 85.7M-11.2% | 96.5M-7.7% | |
| Finance lease liability | — | — | — | 0.00-100.0% | 276K-16.6% | |
| Other non-current liabilities | 90.0K-89.8% | 880K-23.9% | 1.16M-64.7% | 3.28M | 0.00 | |
| 1.19B-22.6% | 1.54B+90.0% | 811M-26.3% | 1.10B-14.8% | 1.29B+223.4% | ||
| Preferred stock | — | — | — | — | 0.00 | |
| Common stock | — | — | — | — | 71.0K+2.9% | |
| Additional paid-in capital | 2.56B+2.5% | 2.49B+2.4% | 2.44B+2.1% | 2.39B+2.2% | 2.33B+4.1% | |
| Retained earnings | -562M-277.2% | -149M+81.9% | -823M-74.8% | -471M-97.1% | -239M+87.0% | |
| Treasury stock | 802M+0.0% | 802M+0.0% | 802M+0.0% | 802M+0.0% | 802M | |
| Total liabilities & equity | 1.30B-22.0% | 1.66B+77.5% | 937M-24.3% | 1.24B-13.8% | 1.44B+68.6% | |
| Common shares issued | 74.7M+1.8% | 73.4M+1.7% | 72.2M+1.3% | 71.3M+1.0% | 70.6M+1.8% | |
| Common shares outstanding | 58.4M+2.3% | 57.2M+2.2% | 55.9M+1.6% | 55.0M+1.3% | 54.3M-21.6% | |
| Shares outstanding (cover) | 58.6M+2.3% | 57.3M+2.0% | 56.2M+1.6% | 55.3M+1.2% | 54.6M-21.5% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -373M+4.3% | -390M-31.7% | -296M+4.3% | -309M+24.0% | -407M-40.1% | ||
| Depreciation & amortization | 5.20M-8.8% | 5.70M-13.6% | 6.60M-21.4% | 8.40M-4.5% | 8.80M-6.4% | |
| Share-based compensation | 52.6M+22.7% | 42.8M-4.3% | 44.8M-9.2% | 49.3M-7.9% | 53.5M-13.1% | |
| Change in receivables | 6.47M+397.9% | 1.30M+115.1% | 604K-72.6% | 2.21M | 0.00 | |
| Change in inventory | 5.30M-37.9% | 8.54M-19.3% | 10.6M+24.6% | 8.49M | 0.00 | |
| Change in payables | 1.75M-73.5% | 6.60M+175.6% | -8.73M-354.2% | 3.44M+84.4% | 1.86M-44.1% | |
| 377M+3.8% | 363M+51.7% | 240M-1.5% | 243M-80.5% | 1.25B+1548.6% | ||
| Capital expenditure | 4.32M+156.1% | 1.69M+68.7% | 999K-79.5% | 4.88M-15.0% | 5.74M-59.3% | |
| Free cash flow | -377M+3.6% | -392M-31.8% | -297M+5.5% | -314M+23.9% | -413M-35.5% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 8.68M-39.9% | 14.4M+165.8% | 5.43M+131.2% | 2.35M+100.3% | -766M-392.8% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 802M | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | 12.9M+207.7% | -12.0M+76.6% | -51.1M+20.1% | -63.9M-184.4% | 75.7M+62.8% | |
| Income taxes paid | 628K-98.5% | 43.1M+2650.2% | 1.57M | 0.00-100.0% | 16.1M | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 1.59B-15.3% | 1.88B+51.3% | 1.24B-19.3% | 1.54B-14.1% | 1.80B-40.4% | |
| P/E | — | 2.8× | — | — | 1.1× | |
| P/S | 29.5×-42.8% | 51.6×-0.4% | 51.8×-66.7% | 155.4× | — | |
| P/B | 1.3×+9.4% | 1.2×-12.9% | 1.4×-4.5% | 1.5×+5.7% | 1.4×-81.6% | |
| Earnings yield | — | 35.8% | — | — | 89.4% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: AGIO’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all AGIO filings on SEC EDGAR → Not investment advice.